(Molina-Montes et al., 2021)
AMCP Nexus in focus: Exploring Primes GLP-1 research in depth Ben Urick, senior director of health outcomes, and Landon Marshall, health outcomes research principal, share more about their educational session and research poster on GLP-1s Prior to the release of Prime Therapeutics (Prime) latest cost-of-care data from its ongoing real-world research on glucagon-like peptide-1 (GLP-1) agonist drugs, Prime researchers presented findings from the Year-2 adherence and persistence study as a research poster and an education session at Academy of Managed Care Pharmacy (AMCP) Nexus 2024 in Las Vegas, Nevada
Licensed treatments such as Wegovy and orlistat are prescribed as part of a structured programme including dietary and behavioural support, and are subject to defined eligibility criteria
Randomised clinical trial: colestyramine vs
At The Johnson Center we only recommend GHK-Cu in an organic base that is suitable for all skin types
She later admitted lying about her cancer